Operational Intent: This performance measure examines how activities have been implemented to achieve the following outcomes
- Support continued planning, development, and implementation of a national system for special pathogen patient care1, including engaging state and jurisdiction special pathogen treatment centers; and other health care facilities (including but not limited to settings such as nursing homes, residential care facilities, EMS, and 911 call centers).
- Support NETEC in their activities as a ‘force amplifier’ in their region.
Required Program Performance Measure |
Data Point(s) |
Data Entity |
Calculation |
|---|
| PM 8: Successes and promising practices in the continued planning, development, and implementation of a national system for special pathogen patient care | What successes have you experienced regarding the continued planning, development, and implementation of a national system for special pathogen patient care using
RESPTC FY20 Administrative Supplement funds? What promising practices were developed/used to achieve that result? (Free response, 750-character response length) | RESPTC | Number of RESPTCs reporting success Qualitative description of promising practices |
|---|
| PM 9: Challenges encountered by RESPTCs in the continued planning, development, and implementation of a national system for special pathogen patient care | What specific challenges or limitations have you encountered regarding your ability to plan, develop, and implement a national system for special pathogen care across sites? (Select all that apply) - Coordination and communication across facilities and partners (free response, 300-character response length)
- Incentivizing participation from key stakeholders (free response, 300-character response length)
- Aligning regional workplans with national NETEC initiatives (free response, 300-character response length)
Other (free response, 600-character response length) | RESPTC | Number of RESPTCs reporting each challenge Qualitative description of challenges |
|---|
| PM 10: Strategies implemented by RESPTCs to access and use information and resources from NETEC | Which of the following strategies did your RESPTC employ to access and use NETEC information and resources usingRESPTC FY20 Administrative Supplement funds? (Select all that apply) Utilized NETEC resources to improve operations and clinicaloutcomes within my RESPTC - Shared NETEC resources with other health care facilities, organizations, and staff
- Participated in the provision of technical assistance by NETEC SMEs for facilities in my region
- Utilized the NETEC infrastructure to support capacity and capability to participate in emergency clinical research2
- Other (free response)
| RESPTC | Number of RESPTCs implementing each listed strategy |
|---|
| PM 11: Coordination and collaboration between RESPTCs and other regional disaster response organizations** | In what ways did your organization engage or partner with other regional organizations for disaster response (e.g., Regional Disaster Health Response System demonstration sites, Health Care Coalitions, etc.) using
RESPTC FY20 Administrative Supplement funds? (Free response, 750-character response length) | RESPTC | Number of RESPTCs collaborating with other regional organizations |
|---|
| PM 12: Regional treatment center initiatives to support their region’s special pathogens system of care | Please briefly describe the major outcomes associated with your RESPTC’s initiatives to support your region’s special pathogen system of care using
RESPTC FY20 Administrative Supplement funds. (Free response - 750-character response length) | RESPTC | Number of RESPTCs implementing initiatives Qualitative description of initiatives |
|---|
| PM 13: Challenges encountered during implementation of regional center initiatives to support their region’s special pathogens system of care | What specific challenges have you had regarding implementation of regional treatment center initiatives to support your region’s special pathogens system of care using
RESPTC FY20 Administrative Supplement funds? (Free response - 750-character response length) | RESPTC | Number of RESPTCs reporting challenges Qualitative description of challenges |
|---|
**Note: A similar question appears in performance measures for the
RESPTC COVID-19 Preparedness and Response Activities Administrative Supplement. Please limit this particular response to activities and outcomes funded by the
RESPTC FY20 Administrative Supplement.
1 Funding for RESPTCs in FY20 built on previous Ebola programming, which specified this activity at the regional level. Due to the COVID-19 pandemic, ASPR sought to evolve the regional system already established through Ebola funding into a National Special Pathogens System (NSPS). In order to capture the true intent of RESPTCs’ role in this system, this document refers to a “national system for special pathogen patient care.” RESPTCs continue to operate regionally within this national system.
2 The Hospital Preparedness Program (HPP) Ebola Preparedness and Response Activities Cooperative Agreement (CFDA #93.817) Part B permits the Regional Ebola and Other Special Pathogen Treatment Centers to participate in clinical research, clinical trials, and experimental protocols, if appropriate, but recipients may not use cooperative agreement funds for research.
<< Previous ---------
Top of Page ---------
Next >>
